Final agreement between Navamedic and Grünenthal for Glucodmed/Flexove marketing in Mexico
Navamedic ASA and Grünenthal GmbH have signed the final agreement for marketing and distribution of Glucomed/Flexove in Mexico.
On the 22 February 2007, Navamedic ASA announced that it had entered into a Heads of Agreement with Grünenthal for marketing and distribution of Glucomed/Flexove in Mexico. It was announced that the final agreement was expected to be formally signed within 30.04.2007. The companies have now issued and signed the final agreement. The agreement has a duration of 10 years.
Grünenthal has already started the product approval process for Glucomed/Flexove. Product launch is expected within 2008.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.